As healthcare needs, biotechnological advancements and pharmaceutical research evolve at pace, Ekium supports life sciences companies through every stage of their industrial projects: design, construction, qualification, validation and product launch.
From designing facilities to produce essential and innovative medicines to building eco-friendly infrastructure, our teams draw on their unique expertise to contribute to projects and initiatives that have a lasting and tangible impact.
of Ekium's activity
Years of experience
Countries (France, Benelux, Spain, Switzerland, Italy, United Kingdom)
Our strength lies in the balance between regulatory compliance, innovation and continuous improvement, an approach focused on making our experts available to our partners.
Working with Ekium involves a collaborative process in which they listen to the client’s needs and propose cutting-edge technical solutions. For a complex project like Cyclotron, Ekium brings thoughtful planning and implementation that is truly tailored to the expected solutions.
Innovation and R&D remain central, with the creation of new molecules, targeted therapies and vaccines. Sustainable production, based on green chemistry and waste reduction, is a priority, while digitalization and artificial intelligence are accelerating drug development.
An ageing population increases the need for treatments against chronic diseases, while antibiotic resistance calls for new therapeutic solutions. Recent health crises are a reminder of the importance of strengthening production capacities and security of supply.
Stricter regulations govern substance safety and clinical trials. Reducing ecological impact is becoming crucial, as is diversifying sources of raw materials to limit dependence on major global producers.
Industrial relocation strengthens health sovereignty and supply chain security. Industry concentration through mergers and acquisitions boosts competitiveness, while equitable access to medicines remains a global challenge.
Our aim is to become the benchmark partner in Spain for the design of sustainable, safe and competitive industrial plants whose main function is to develop products that help improve our daily lives.
Complete EPCM mission (design, construction supervision and project management) for the new germanium-68 production building at the Institut des Radioéléments (IRE), including the integration of a cyclotron and hot cells for nuclear medicine.
Detailed engineering, construction and site supervision for the expansion of the Novartis plant with 2 new sterile antibiotic production lines. The mission covered the entire project cycle, guaranteeing compliance with the customer's schedule, budget and quality objectives.
Expansion of an Advanced Therapies Manufacturing platform to increase manufacturing capacity for clinical trials in cell and gene therapy.
Delivered a new GMP cleanroom capacity incorporating Grade A processing and two ISO Class 7 cleanrooms, within the constraints of a fully operational hospital, without disrupting patient care or surrounding clinical activity.
Evaluation, design and implementation of a gravity-fed manufacturing process for the relocation of a production unit in an existing building.
Our multidisciplinary team has extensive experience in pharmaceutical design and qualification, cell and gene therapy, and animal health.
The "Industrial Decarbonization" award has been presented to Ekium for the project it carried out on behalf of EUROAPI: the development of a strategic, technical, and economic roadmap for 2030 and 2050 aimed at achieving carbon neutrality and reducing energy and water consumption.
Established in Switzerland since 2020, Ekium is supported by a team of versatile engineers and senior project managers who combine technical excellence with in-depth knowledge of the Swiss context: standards, industrial practices and the local ecosystem.
In the face of the challenges posed by industrial transformation, Ekium draws on its multidisciplinary expertise to anticipate the challenges of tomorrow. Our teams of engineers and project managers implement innovative solutions that span the entire industrial value chain.
The Snef Group operates across four continents—the Americas, Europe, Africa, and Oceania—in 30 countries and 80 cities, with a network spanning more than 100 international locations.
